title: Vitamin D3-24-hydroxylase (CYP24) as a potential target for intervention with diabetic and nondiabetic nephropathy.
authors.affiliation: GTX Pharmaceuticals, Griöbenzell, Germany. hans.weiher@fh-bonn-rhein-sieg.de
authors.forename: Hans
authors.initials: H
authors.lastname: Weiher
authors.forename: Ralf M
authors.initials: RM
authors.lastname: Zwacka
mesh_terms: D000818:Animals; D003928:Diabetic Nephropathies / Q000235:genetics / Q000378:metabolism*; D005260:Female; D020869:Gene Expression Profiling; D005921:Glomerulonephritis / Q000235:genetics / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D008565:Membrane Proteins / Q000235:genetics*; D051379:Mice; D016688:Mice, Inbred NOD; D018345:Mice, Knockout
chemical_list: D008565:Membrane Proteins; C065292:Mpv17 protein, mouse